Protein C Levels As a Prognostic Indicator of Outcome in Sepsis and Related Diseases
Overview
Emergency Medicine
Authors
Affiliations
Objective: To consider the appropriateness of protein C levels as a prognostic indicator for sepsis and related diseases.
Data Sources/study Selection: Published research and review articles related to protein C deficiency in patients with sepsis and related diseases.
Data Extraction And Synthesis: All applicable data were extracted, and relevant literature was cited to support factual statements in the text. The protein C pathway represents one of the major regulatory systems of hemostasis, exhibiting antithrombotic, profibrinolytic, and anti-inflammatory properties. Numerous studies have shown that acquired protein C deficiency is prevalent in the majority of septic patients (>85%) and is associated with increased morbidity and mortality in patients with severe sepsis and septic shock. This deficiency in protein C is not simply a transient marker for sepsis, but parallels the progress of the disease. In addition, protein C deficiency occurs in the presence of a wide range of pathogens and develops early in the disease process.
Conclusions: A review of the relevant literature suggests that protein C levels may serve as a useful prognostic indicator of outcome in sepsis and related diseases.
Activated Protein C in Cutaneous Wound Healing: From Bench to Bedside.
Zhao R, Lin H, Bereza-Malcolm L, Clarke E, Jackson C, Xue M Int J Mol Sci. 2019; 20(4).
PMID: 30791425 PMC: 6412604. DOI: 10.3390/ijms20040903.
The Emperor Has No Clothes? Searching for Dysregulation in Sepsis.
Alcock J J Clin Med. 2018; 7(9).
PMID: 30158480 PMC: 6162833. DOI: 10.3390/jcm7090247.
Greineder C, Johnston I, Villa C, Gollomp K, Esmon C, Cines D Blood Adv. 2018; 1(18):1452-1465.
PMID: 29296786 PMC: 5727853. DOI: 10.1182/bloodadvances.2017007229.
Minhas N, Xue M, Jackson C Cell Mol Life Sci. 2016; 74(10):1895-1906.
PMID: 28005151 PMC: 11107519. DOI: 10.1007/s00018-016-2440-6.
Protein C zymogen in severe sepsis: a double-blinded, placebo-controlled, randomized study.
Pappalardo F, Crivellari M, Di Prima A, Agracheva N, Celinska-Spodar M, Lembo R Intensive Care Med. 2016; 42(11):1706-1714.
PMID: 27344436 DOI: 10.1007/s00134-016-4405-5.